Head-To-Head Survey: Health In Tech (HIT) & Its Rivals

Health In Tech (NASDAQ:HIT) is one of 96 publicly-traded companies in the “Healthcare Technology” industry, but how does it contrast to its rivals? We will compare Health In Tech to related companies based on the strength of its valuation, institutional ownership, dividends, earnings, analyst recommendations, risk and profitability.

Risk & Volatility

Health In Tech has a beta of 2.82, indicating that its share price is 182% more volatile than the S&P 500. Comparatively, Health In Tech’s rivals have a beta of 1.12, indicating that their average share price is 12% more volatile than the S&P 500.

Profitability

This table compares Health In Tech and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Health In Tech Competitors	-768.40%	-39.53%	-18.05%

Insider and Institutional Ownership

41.7% of shares of all “Healthcare Technology” companies are owned by institutional investors. 77.7% of Health In Tech shares are owned by insiders. Comparatively, 15.9% of shares of all “Healthcare Technology” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Health In Tech and its rivals revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Health In Tech	$32.83 million	N/A	-14.29
Health In Tech Competitors	$329.71 million	-$23.71 million	13.22

Health In Tech’s rivals have higher revenue, but lower earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and price targets for Health In Tech and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	1	1	2.67
Health In Tech Competitors	431	1491	2722	87	2.52

Health In Tech presently has a consensus target price of $3.50, suggesting a potential upside of 249.93%. As a group, “Healthcare Technology” companies have a potential upside of 49.69%. Given Health In Tech’s stronger consensus rating and higher probable upside, analysts plainly believe Health In Tech is more favorable than its rivals.

Summary

Health In Tech beats its rivals on 8 of the 12 factors compared.

Health In Tech Company Profile

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.